VeriTeQ delivers 2,000 Q Inside Safety Technology transponders, which
are being used to uniquely identify EL’s next generation breast implants
DELRAY BEACH, Fla.--(BUSINESS WIRE)--
VeriTeQ Corporation (“VeriTeQ” or the “Company”, f/k/a/ Digital Angel
Corporation) (OTC Markets: DIGAD), a provider of implantable medical
device identification and radiation dose measurement technologies,
announced today that it has delivered its first order of 2,000 Q Inside
Safety Technology radio frequency identification microchips to breast
implant partner Establishment Labs, S.A. (“EL”). VeriTeQ’s Q Inside
Safety Technology is the Company’s unique device identifier, or UDI, for
implantable and reusable medical device identification. EL’s Motiva
Implant Matrix Ergonomix™ with VeriTeQ’s Q Inside Safety Technology is
the world’s first externally identifiable breast implant.
By including VeriTeQ’s Q Inside Safety Technology, which is an FDA
cleared radio frequency identification microchip that can be read safely
from outside the body, in Motiva implants, physicians and patients will
have access to a secure online database to retrieve implant-specific
data such as serial number, manufacturer name, date of manufacture, lot
number, volume, size, and other data. Q Inside Safety Technology also
provides an extra level of protection to the patient in the event of a
recall or other safety event.
The companies announced recently that EL received CE mark approval to
market its Motiva Implant Matrix Ergonomix™ with VeriTeQ’s Q Inside
Safety Technology. CE Mark approval enables EL to market its Motiva
breast implants to patients in 28 countries in the European Union and
fast track regulatory approvals in many countries in South America,
Middle East and Asia.
Scott R. Silverman, Chairman and CEO of VeriTeQ, stated, “We are very
pleased to help EL prepare for the upcoming international launch of
their new implant, the Motiva Implant Matrix Ergonomix™ with VeriTeQ’s Q
Inside Safety Technology, which we believe is a best-in-class product.
We are gearing up to deliver additional microchips and readers to EL on
an ongoing, monthly basis.”
According to the International Society of Aesthetic Plastic Surgery, the
number of breast augmentation procedures performed worldwide in 2011
exceeded 1.2 million.
In September 2012, VeriTeQ entered into a development and supply
agreement with EL, a global provider of breast implants under the Motiva
Implant Matrix® brand name, to build next-generation breast implants
that contain VeriTeQ’s Unique Device Identifier (“UDI”) called “Q Inside
Safety Technology.” Under the terms of the agreement, VeriTeQ will
receive payments from EL for the implantable microchips used in each
implant, as well as external handheld readers.